Grifols, S.A. (NASDAQ:GRFS) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET
Company Participants
Nuria Pascual - IR
Thomas Glanzmann - Executive Chairman
Victor Grifols Deu - Co-CEO
Alfredo Arroyo - CFO
Conference Call Participants
Peter Verdult - Citi
Rosie Turner - Jefferies
Elizabeth Walton - Credit Suisse
Tom Jones - Berenberg
James Gordon - JP Morgan
Guilherme Macedo - CaixaBank
Jaime Escribano - Banco Santander
Thibault Boutherin - Morgan Stanley
Charles Pitman - Barclays
Alvaro Lenze - Alantra Equities
Juan Ros - ODDO BHF
Nuria Pascual
Hello, everyone, and welcome to Grifols' Full Year 2022 Conference Call. Thank you very much for taking the time to join us today. This is Nuria Pascual speaking, Investor Relations and Sustainability Officer. And I'm joined by Thomas Glanzmann, our Executive Chairman; Victor Grifols Deu and Raimon Grifols, our Co-CEOs and Alfredo Arroyo, CFO of Grifols.
We anticipate that this call will last for about 60 minutes. There will be a presentation of approximately 35 minutes followed by a Q&A session. [Operator Instructions] As a reminder, this call is being recorded. And the materials for the call are on the Investor Relations section of grifols.com.
Before we start, I draw your attention to the forward-looking statement disclaimer on Slide 2 in the slide deck of our release. Forward-looking statements on the call are subject to substantial risks and uncertainties, speak only as of the call's original date, and we undertake no obligation to update or revise any of these statements.
With that, I would like to turn the call over to Thomas.
Thomas Glanzmann
Thank you, Nuria, and thank you, everyone for joining the call today. By now, you all are aware that we have had a change of the guard in the position of Executive Chairman. The Board with great respect accepted the resignation of Steve Mayer, who made the decision to step down for health and personal reasons.
Effective February 22, I stepped into the role and I would at this point like to thank Steve for the valuable work and contribution he made over the past month and 12 years as a Grifols Board member. Needless to say, I and the Board wish him all the best as he moves on to another chapter in his life.
For those that do not know me or I have not had an opportunity to meet at one of our investor meetings, let me briefly introduce myself. I've been on the Grifols Board for almost 17 years and in recent years was the company's Vice Chairman. I have been associated with the plasma and diagnostics industries since the late 1980s, and I have been a CEO of plasma, biologics, reno, and diagnostics companies during my career.